TherapeuticsMD Inc reports results for the quarter ended in September - Earnings Summary

TherapeuticsMD

11/11/2021 14:31

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss of 11 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 10 cents per share.
* Revenue fell 95.2% to $937.00 thousand from a year ago; 
analysts expected $25.87 million. 
* TherapeuticsMD Inc's reported EPS for the quarter was a loss
of 11 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TherapeuticsMD Inc shares had fallen by 3.4% this quarter and
lost 40.8% so far this year.
* The company reported a quarterly loss of $47.42 million.
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated